Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Expression of Optic Atrophy Type 1 (OPA1) Protein in Lung Adenocarcinoma

NCT01249053 is registered in ClinicalTrials.gov with China Medical University Hospital as lead sponsor.

NCT NCT01249053
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01249053 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Expression of Optic Atrophy Type 1 (OPA1) Protein in Lung Adenocarcinoma
Lead sponsor
China Medical University Hospital
Phase
Observational
Overall status
Unknown status
Start date
August 31, 2010
Completion date
Not reported
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung adenocarcinoma